MY195946A - Antibody Constructs for DLL3 and CD3 - Google Patents

Antibody Constructs for DLL3 and CD3

Info

Publication number
MY195946A
MY195946A MYPI2021000804A MYPI2021000804A MY195946A MY 195946 A MY195946 A MY 195946A MY PI2021000804 A MYPI2021000804 A MY PI2021000804A MY PI2021000804 A MYPI2021000804 A MY PI2021000804A MY 195946 A MY195946 A MY 195946A
Authority
MY
Malaysia
Prior art keywords
antibody construct
dll3
polynucleotide
antibody constructs
binds
Prior art date
Application number
MYPI2021000804A
Inventor
Jochen Pendzialek
Christoph Dahlhoff
Ralf Lutterbuese
Elisabeth Nahrwold
Claudia Bluemel
Tobias Raum
Patrick Hoffmann
Peter Kufer
Original Assignee
Amgen Res Munich Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Res Munich Gmbh filed Critical Amgen Res Munich Gmbh
Priority to MYPI2021000804A priority Critical patent/MY195946A/en
Publication of MY195946A publication Critical patent/MY195946A/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to a bispecific antibody construct comprising a first binding domain which binds to human CD70 on the surface of a target cell and a second binding domain which binds to human CD3 on the surface of a T cell. Moreover, the invention provides a polynucleotide encoding the antibody construct, a vector comprising said polynucleotide and a host cell transformed or transfected with said polynucleotide or vector. Furthermore, the invention provides a process for the production of the antibody construct of the invention, a medical use of said antibody construct and a kit comprising said antibody construct.
MYPI2021000804A 2016-08-01 2016-08-01 Antibody Constructs for DLL3 and CD3 MY195946A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI2021000804A MY195946A (en) 2016-08-01 2016-08-01 Antibody Constructs for DLL3 and CD3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI2021000804A MY195946A (en) 2016-08-01 2016-08-01 Antibody Constructs for DLL3 and CD3

Publications (1)

Publication Number Publication Date
MY195946A true MY195946A (en) 2023-02-27

Family

ID=87569478

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2021000804A MY195946A (en) 2016-08-01 2016-08-01 Antibody Constructs for DLL3 and CD3

Country Status (1)

Country Link
MY (1) MY195946A (en)

Similar Documents

Publication Publication Date Title
PH12018500241A1 (en) Antibody constructs for dll3 and cd3
PH12018500216A1 (en) Antibody constructs for cd70 and cd3
PH12018500156A1 (en) Antibody constructs for egfrviii and cd3
PH12018500157A1 (en) Antibody constructs for flt3 and cd3
PH12018500107A1 (en) Bispecific antibody constructs binding mesothelin and cd3
MX2021008367A (en) Antibody constructs for cdh19 and cd3.
SG10201909308XA (en) Bispecific antibody constructs for cdh3 and cd3
EA201890390A8 (en) SPECIFIC ANTIBODY STRUCTURES BINDING EGFRvIII AND CD3
MX2017001401A (en) Optimized cross-species specific bispecific single chain antibody constructs.
MX2017001403A (en) Bispecific single chain antibody construct with enhanced tissue distribution.
PH12015501651B1 (en) Antibody constructs for cdh19 and cd3
MY195946A (en) Antibody Constructs for DLL3 and CD3